News | Artificial Intelligence | May 20, 2019

Research study demonstrates healthcare artificial intelligence application to detect and triage pulmonary nodules

AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up

May 20, 2019 — Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments on radiology reports from emergency departments, inpatient and outpatient healthcare facilities, Digital Reasoning used natural language processing (NLP) and machine learning (ML) to identify and triage high-risk lung nodules, achieving queue precision of 90.2 percent. The findings have now been published in the Journal of Clinical Oncology as part of the 2019 American Society of Clinical Oncology (ASCO) meeting proceedings.1

For health systems, reviewing incidental findings can be a time and labor intensive process.2 Other studies show the rate for timely clinical follow-up can fall as low as 29 percent across the industry.3 Applying advanced artificial intelligence (AI) to radiology reports to automate the identification and triage of pulmonary nodules, empowers doctors to focus on reviewing and acting on the most high-risk cases. This results in improved patient safety and faster time-to-treatment without excess labor.

During the research study, Digital Reasoning analyzed 8,879 free-text, narrative computed tomography (CT) radiology reports from Dec. 8, 2015 through April 23, 2017.  Today, those analytics are embedded in an enterprise solution utilized across more than 150 hospitals and 60 cancer centers in the United States.

For more information: www.ascopubs.org/journal/jco

References

1. French C., Makowski M., Terker S., et al. Automating incidental findings in radiology reports using natural language processing and machine learning to identify and classify pulmonary nodules. Presented at ASCO 2019. J Clin Oncol 37, 2019 (suppl; abstr e18093)

2. Rosenkrantz A.B., Xue X., Gyftopoulos S., et al. Downstream Costs Associated with Incidental Pulmonary Nodules Detected on CT. Acad Radiol., published online Aug. 6, 2018. pii: S1076-6332(18)30372-6, 2018

3. Blagev D.P., Lloyd J.F., Conner K., et al. Follow-up of Incidental Pulmonary Nodules and the Radiology Report. J Am Coll Radiol., published online Dec. 6, 2013. 13(2 Suppl):R18-24, 2016


Related Content

News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True ...

Time April 03, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Computed Tomography (CT)

March 30, 2026 — HCA Healthcare’s Good Samaritan Hospital is the first hospital in the Bay Area to implement Lumina 3D ...

Time April 01, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
Subscribe Now